LONDON--(BUSINESS WIRE)--OatWell™, a source of 100% natural oat beta-glucan, today announced the launch of its cholesterol-lowering food products available at leading Boots stores throughout the United Kingdom.
OatWell™ contains high amounts of oat beta-glucan, which is the valuable soluble fibre found naturally within oats. With the recommended intake of 3g daily, oat beta-glucan has been proven to lower cholesterol levels without side effects, helping reduce the risk of heart disease. The European Food Safety Authority (EFSA) has recognised OatWell™, officially confirming oat beta-glucan’s health-promoting effects.1
In addition, with more than 100 scientific studies validating the benefits of oat beta-glucan, UK consumers can now get their daily dosage through the following three products:
- OatWell™ Original Powder: One scoop (11g) of OatWell™ Original powder per day contains 3g of oat beta-glucan, enough to reduce blood cholesterol levels, and equal to eating three bowls of porridge oats. It can be sprinkled once a day onto yoghurt, cereal or porridge and can also be used for baking. Alternatively, add 1 scoop into a glass, add 200ml-250ml of milk, water or fruit juice. OatWell™ Original is available in a tub with a 28 day supply.
- OatWell™ Instant Drink Mix: One OatWell™ Instant Drink Mix sachet contains 3g of oat beta-glucan and is equal to eating three bowls of porridge oats. One Oatwell™ shake per day is enough to reduce blood cholesterol. OatWell™ Instant Drink Mix is available in Strawberry, Vanilla and Chocolate flavours and comes with a 14 day supply.
- OatWell™ Cereal Bars: One OatWell™ Cereal Bar contains 3g of oat beta-glucan. This is equivalent to eating three bowls of porridge oats. Eating one OatWell™ bar a day is enough to actively reduce blood cholesterol levels. OatWell™ Cereal Bars are available in Apple Crumble, Chocolate and Caramel flavours.
“OatWell’s™ oat beta-glucan has been present in several products available around the world for many years. With its new line of OatWell™ branded products, UK consumers can now access the best of nature and science to lower cholesterol levels,” said Rob Winwood, Scientific Communications Manager at DSM Nutritional Products. “Without side effects, oat beta-glucan makes an excellent alternative to statins and sterols/stanols, and we hope that people of all ages will experience the benefit of oat beta-glucan to their heart health.”
OatWell products have also been approved by HEART UK, The Cholesterol Charity. Linda Main, HEART UK Registered Dietician and Nutritionist stated, “Coronary Heart Disease (CHD) remains the number one cause of death in the United Kingdom. High cholesterol is a primary risk factor for CHD and can even affect people in their 20s, 30s and 40s through an inherited condition. HEART UK recommends eating a diet where saturated fats are replaced by unsaturated fats and which includes cholesterol busting foods such as those rich in oat beta-glucans. The OatWell™ range of foods is the only one currently on the UK market that provide all 3g (the recommended amount) in a single serving.”
OatWell™ is available in the health aisles of Boots stores throughout the United Kingdom and online here.
About OatWell™
OatWell™ is a 100% natural oat bran, containing high amounts of valuable oat beta-glucan, which is the soluble fibre found naturally within oats. More than 100 scientific studies have proven the positive effects of oat beta-glucan on cholesterol levels. These positive effects of oat beta-glucan were first discovered in the 1960s and have been continually researched since. Starting May 2014, available OatWell™ products on the UK market include: OatWell™ Original Powder, OatWell™ Cereal Bars and OatWell™ Instant Drink Mix. The products can be found at leading Boots stores nationwide and online here. OatWell™ is a registered trademark of DSM Nutritional Products Ltd. It is distributed in the UK by Inovate Health. For more information on OatWell™ products, please visit this link. Friend us on Facebook and follow us on Twitter.
__________________________
1 Following an application
from the OatWell® manufacturer, the EU Commission has given
final authorization on the oat beta-glucan disease risk reduction health
claim and published in the Official Journal of the European Union on 15
November 2011 (Commission Regulation (EU) NO 1160/2011).
